Hematopoietic and Lymphatic System Neoplasm Clinical Trials

53 studies are recruiting for hematopoietic and lymphatic system neoplasm in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Rochester, Minnesota 13 Duarte, California 10 Jacksonville, Florida 9 Seattle, Washington 9 Ann Arbor, Michigan 6 Scottsdale, Arizona 6 Chicago, Illinois 5 Los Angeles, California 5 Portland, Oregon 5 Columbus, Ohio 4 Houston, Texas 4 Irvine, California 4 Oklahoma City, Oklahoma 4 Albuquerque, New Mexico 3 Atlanta, Georgia 3 Aurora, Colorado 3 Bethesda, Maryland 3 Durham, North Carolina 3 Effingham, Illinois 3 Little Rock, Arkansas 3 Memphis, Tennessee 3 Minneapolis, Minnesota 3 Nashville, Tennessee 3 New Haven, Connecticut 3 New Orleans, Louisiana 3 Phoenix, Arizona 3 Springfield, Illinois 3 St Louis, Missouri 3 Tampa, Florida 3 The Bronx, New York 3 Wilmington, Delaware 3 Winston-Salem, North Carolina 3

Studies, page 3

  1. Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety in Rural Older Cancer Survivors

    This clinical trial tests how well a web based toolkit works to improve cancer related emotional distress and anxiety in rural older cancer survivors. Rural older adults with cancer-related distress are particularly vulnerable to poorer mental health and cancer-related outcomes including increased …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Northwestern University, Chicago, Illinois
    Run by
    Northwestern University

    See if you can join NCT07290543 on ClinicalTrials.gov

  2. Two Step Haplo With Radiation Conditioning

    This phase II clinical trial evaluates whether a modified modality of conditioning reduces treatment-related mortality (TRM) in patients who undergo a hematopoietic stem cell transplant (HSCT) for a hematological malignancy. HSCT is a curative therapy for many hematopoietic malignancies, however th…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadephia, Pennsylvania
    Run by
    Thomas Jefferson University

    See if you can join NCT05031897 on ClinicalTrials.gov

  3. Q702 for the Treatment of Patients With Hematologic Malignancies

    This phase I trial tests the safety, side effects, and best dose of Q702 in treating patients with hematologic malignancies. Q702 is in a class of medications called immunomodulatory agents. It works by helping the immune system kill cancer cells and by helping the bone marrow to produce normal blo…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Mayo Clinic in Arizona, Scottsdale, Arizona
    Locations
    2 in total
    Run by
    Mayo Clinic

    See if you can join NCT06712810 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.